DK0830345T3 - Styryl-benzimidazol-derivater som inhibitorer af glatmuskel-celleproliferation - Google Patents

Styryl-benzimidazol-derivater som inhibitorer af glatmuskel-celleproliferation

Info

Publication number
DK0830345T3
DK0830345T3 DK96916978T DK96916978T DK0830345T3 DK 0830345 T3 DK0830345 T3 DK 0830345T3 DK 96916978 T DK96916978 T DK 96916978T DK 96916978 T DK96916978 T DK 96916978T DK 0830345 T3 DK0830345 T3 DK 0830345T3
Authority
DK
Denmark
Prior art keywords
inhibitors
cell proliferation
smooth muscle
muscle cell
benzimidazole derivatives
Prior art date
Application number
DK96916978T
Other languages
Danish (da)
English (en)
Inventor
Hassan Mahmoud Elokdah
Theodore Sylvester Sulkowski
Sie-Yearl Chai
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of DK0830345T3 publication Critical patent/DK0830345T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK96916978T 1995-06-06 1996-06-03 Styryl-benzimidazol-derivater som inhibitorer af glatmuskel-celleproliferation DK0830345T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/468,271 US6444694B1 (en) 1995-06-06 1995-06-06 Styryl benzimidazole derivatives
PCT/US1996/008375 WO1996039391A1 (en) 1995-06-06 1996-06-03 Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation

Publications (1)

Publication Number Publication Date
DK0830345T3 true DK0830345T3 (da) 2001-11-19

Family

ID=23859136

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96916978T DK0830345T3 (da) 1995-06-06 1996-06-03 Styryl-benzimidazol-derivater som inhibitorer af glatmuskel-celleproliferation

Country Status (19)

Country Link
US (1) US6444694B1 (ja)
EP (1) EP0830345B1 (ja)
JP (1) JPH11506753A (ja)
KR (1) KR19990022266A (ja)
CN (1) CN1192206A (ja)
AR (1) AR002749A1 (ja)
AT (1) ATE205196T1 (ja)
AU (1) AU711965B2 (ja)
BR (1) BR9609153A (ja)
CA (1) CA2223585A1 (ja)
DE (1) DE69615023T2 (ja)
DK (1) DK0830345T3 (ja)
ES (1) ES2162063T3 (ja)
HU (2) HUP9900914A2 (ja)
IL (1) IL118385A0 (ja)
NZ (1) NZ309499A (ja)
PT (1) PT830345E (ja)
WO (1) WO1996039391A1 (ja)
ZA (1) ZA964693B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
DK1718608T3 (da) 2004-02-20 2013-10-14 Boehringer Ingelheim Int Virale polymeraseinhibitorer
CA2618682C (en) 2005-08-12 2011-06-21 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
EP2035369B1 (en) 2006-07-05 2014-06-25 Fibrotech Therapeutics PTY LTD Therapeutic compounds
WO2011047432A1 (en) * 2009-10-22 2011-04-28 Fibrotech Therapeutics Pty Ltd Fused ring analogues of anti-fibrotic agents
WO2018144620A1 (en) 2017-02-03 2018-08-09 Shire Human Genetic Therapies, Inc. Anti-fibrotic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575956A (en) * 1967-07-24 1971-04-20 Sterling Drug Inc 2-substituted-benz-x-azol-6-ylazo-aminonaphthalene compounds
DE1670908A1 (de) * 1967-08-16 1971-04-29 Hoechst Ag Neue Benzimidazolverbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung als optische Aufhellungsmittel
FR2104717A1 (en) * 1970-09-28 1972-04-21 Dynachim Sarl Organophosphorus pesticides stabilised with benzimidazole derivs - - for controlling insects and internal parasites of animals
DE3505609A1 (de) 1985-02-19 1986-08-21 Merck Patent Gmbh, 6100 Darmstadt Benzimidazolyl-pyridazinone
JPH05507072A (ja) 1990-04-16 1993-10-14 イッスム　リサーチ　ディヴェロプメント　カンパニー　オブ　ザ　ヒーブルー　ユニヴァーシティ　オブ　エルサレム Ｅｇｆレセプタチロシンキナーゼを阻害する複素環式エテンジイル化合物
US5196446A (en) 1990-04-16 1993-03-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Certain indole compounds which inhibit EGF receptor tyrosine kinase
DE4212748A1 (de) 1992-04-16 1993-10-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5387600A (en) 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions

Also Published As

Publication number Publication date
MX9709647A (es) 1998-07-31
HUP9900914A2 (hu) 1999-07-28
BR9609153A (pt) 1999-05-04
DE69615023T2 (de) 2002-06-06
PT830345E (pt) 2002-01-30
AU5968496A (en) 1996-12-24
CA2223585A1 (en) 1996-12-12
AR002749A1 (es) 1998-04-29
EP0830345A1 (en) 1998-03-25
DE69615023D1 (de) 2001-10-11
HUP9900679A3 (en) 2001-07-30
HUP9900679A2 (hu) 1999-09-28
EP0830345B1 (en) 2001-09-05
ZA964693B (en) 1997-12-05
WO1996039391A1 (en) 1996-12-12
KR19990022266A (ko) 1999-03-25
ES2162063T3 (es) 2001-12-16
AU711965B2 (en) 1999-10-28
IL118385A0 (en) 1996-09-12
CN1192206A (zh) 1998-09-02
ATE205196T1 (de) 2001-09-15
JPH11506753A (ja) 1999-06-15
NZ309499A (en) 2000-08-25
US6444694B1 (en) 2002-09-03

Similar Documents

Publication Publication Date Title
DK115791A (da) Heparinfragmenter som inhibitorer af proliferering af glatte muskelceller
NO20013335D0 (no) Anvendelse av 4-H-1-benzopyran-4-on-derivater som inhibitorer av glatt muskelcelle proliferering
NO980467D0 (no) 4-mercaptopyrrolidin-derivater som farnesyl-transerase-inhibitorer
FI951001A (fi) Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina
DK125796A (da) I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet
DE69637328D1 (de) Zelladhäsionsinhibitoren
FI962800A (fi) Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
NO992725L (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
NO995267L (no) Leptin som en inhibitor av tumorcelleproliferering
NO974043D0 (no) Indolderivater som EAA-antagonister
DK0830345T3 (da) Styryl-benzimidazol-derivater som inhibitorer af glatmuskel-celleproliferation
DK0696194T3 (da) Anvendelse af indolderivater som 5HT1-antagonister
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
NO933699D0 (no) Sulfaterte polysakkarider som hemmere av glatt muskelcelleproliferasjon
NO20016403L (no) Substituerte purinderivater som inhibitorer av celleadhesjon
FI951002A0 (fi) Sulfatoituja beta-glykolipidijohdannaisia soluadheesioinhibiittoreina
ATE209635T1 (de) 2-substituierte benzimidazolderivate als inhibitoren der glatten muskelzellenproliferation
AU5967396A (en) Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
KR970004057U (ko) 선반 횡대지지구용 고정구
KR970009903U (ko) 합판고정구
NO912276L (no) Heparinfragmenter som hemmere av proliferasjon av glatte muskelceller.
KR970018326U (ko) 비늘창의 비닐창살 고정장치
ITMI950030A0 (it) Composti indolici
ITMI951687A0 (it) Composti indolici
NO20000860D0 (no) Syklopeptidderivater som adhesjonsinhibitorer